Detalles de la búsqueda
1.
Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
Cancer Sci
; 110(9): 2690-2699, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31250942
2.
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Breast Cancer Res
; 18(1): 73, 2016 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27368476
3.
Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer.
Cancer Sci
; 107(4): 491-8, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26801869
4.
Prediction of sentinel lymph node status using single-photon emission computed tomography (SPECT)/computed tomography (CT) imaging of breast cancer.
Surg Today
; 46(2): 214-23, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25893769
5.
Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.
Cancer Immunol Immunother
; 62(2): 383-91, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22926062
6.
[A case of estrogen receptor-positive metastatic breast cancer in a postmenopausal woman treated with ethinyl estradiol].
Gan To Kagaku Ryoho
; 40(13): 2569-71, 2013 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-24335372
7.
Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer.
Breast Cancer Res Treat
; 134(1): 89-100, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22203435
8.
Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer.
Oncol Lett
; 17(2): 2177-2186, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30675282
9.
Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin.
Oncotarget
; 9(39): 25545-25556, 2018 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29876007
10.
Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer.
Mol Clin Oncol
; 7(1): 24-26, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28685069
11.
Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.
Breast Cancer
; 24(3): 473-482, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27628678
12.
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
Breast Cancer
; 23(6): 830-843, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467036
13.
The HSP70 and autophagy inhibitor pifithrin-µ enhances the antitumor effects of TRAIL on human pancreatic cancer.
Mol Cancer Ther
; 12(4): 341-51, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23371857
14.
Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.
Breast Cancer
; 24(4): 642, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28378258
15.
Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.
Diagn Pathol
; 5: 75, 2010 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21106111
Resultados
1 -
15
de 15
1
Próxima >
>>